We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Report Aims to Untangle Pharmaceutical Supply Chain for Policymakers
Report Aims to Untangle Pharmaceutical Supply Chain for Policymakers
April 4, 2005
The pharmaceutical supply chain involves multiple organizations playing sometimes overlapping roles in product distribution and contracting, but drugmakers clearly have the most influence in establishing prices, according to a new report that explains the multistep path a drug takes from manufacturer to patient.